Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v2.4.0.8
CONDENSED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Current assets:    
Cash $ 7,450 $ 11,798
Receivables 4,143 4,818
Prepaid expenses and other current assets 266 204
Total current assets 11,859 16,820
Property and equipment, net 1,357 1,603
Total assets 13,216 18,423
Current liabilities:    
Accounts payable 4,362 5,118
Accrued clinical trials expenses 173 118
Other accrued liabilities 343 293
Deferred contract revenue 2,583 5,317
Total current liabilities 7,461 10,846
Warrant liabilities 1,504 1,817
Total liabilities 8,965 12,663
Commitments and contingencies      
Stockholders' equity:    
Common stock, at amounts paid-in 284,449 284,485
Additional paid-in capital 22,149 21,692
Accumulated deficit (302,347) (300,417)
Total stockholders' equity 4,251 5,760
Total liabilities and stockholders’ equity $ 13,216 $ 18,423